TRH by slow, continuous infusion: an antidepressant?

Psychol Med. 1976 Aug;6(3):393-7. doi: 10.1017/s0033291700015828.

Abstract

A slow, continuous infusion of 1000 mug TRH (thyrotropin releasing hormone) over a period of 4 h had a very faint and diffuse short-lasting beneficial effect on a group of 10 depressive patients. This was assessed in a double blind cross-over trial with placebo. The effect was of no therapeutic value. No difference was found between the depressive patients and a control group of normal subjects in TSH response, T3 resin uptake, T4 or free thyroxine index values as a consequence of the TRH infusion.

Publication types

  • Clinical Trial
  • Controlled Clinical Trial

MeSH terms

  • Adjustment Disorders / drug therapy
  • Adult
  • Bipolar Disorder / drug therapy
  • Chronic Disease
  • Clinical Trials as Topic
  • Depression / drug therapy*
  • Dose-Response Relationship, Drug
  • Female
  • Humans
  • Infusions, Parenteral
  • Male
  • Mental Status Schedule
  • Middle Aged
  • Thyrotropin / blood
  • Thyrotropin-Releasing Hormone / administration & dosage*

Substances

  • Thyrotropin-Releasing Hormone
  • Thyrotropin